Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.
Stock data | 2024 | Change |
---|---|---|
Price | $0.66000003 | N/A |
Market Cap | $1.65M | N/A |
Shares Outstanding | 2.49M | N/A |
Employees | 15.00 | N/A |